Abstract
Idiosyncratic drug-induced liver injury (DILI) is a rare form of liver injury that occurs in patients taking therapeutic doses of drugs. While idiosyncratic hepatotoxic drugs are not structurally or chemically related, most drugs that cause DILI have been shown to “stress” mitochondria through inhibition of mitochondrial respiration, increased mitochondrial reactive oxygen species (ROS) generation, and other changes that disrupt mitochondrial homeostasis. In most cases, hepatocytes adapt to drug-induced mitochondrial stress by activating adaptation signaling pathways, including mitochondrial adaptive responses such as autophagy/mitophagy, mitochondrial remodeling, and alterations in mitochondrial fusion-fission. Due to these adaptations, drug intake alone is not sufficient to cause liver injury, with acetaminophen being the notable exception. Idiosyncratic DILI involves other extrinsic factors, including inflammation and the adaptive immune system. Inflammation may promote DILI because mitochondrial stress (i.e., increased mitochondrial ROS generation) induced by hepatotoxic drugs can inhibit adaptation/survival signaling pathways, such as NF-κB, needed to withstand the cytotoxic effects of tumor necrosis factor-α (TNF) released during inflammation. If mitochondrial and hepatocellular injury reach a critical threshold, death signaling pathways involving c-Jun N-terminal kinase (JNK) that target mitochondria become activated. Binding of activated JNK to mitochondria triggers the mitochondrial permeability transition (MPT) that results in hepatocyte death and liver injury. Mitochondria, therefore, play a critical role in all stages of DILI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ALT:
-
Alanine aminotransferase
- AMPK:
-
AMP-activated protein kinase
- APAP:
-
Acetaminophen
- ARE:
-
Antioxidant response element
- ASK1:
-
Apoptosis signal-regulating kinase 1
- Bcl-2:
-
B-cell lymphoma-2
- Cu3:
-
Cullin-dependent E3 ubiquitin ligase complex
- CYP450:
-
Cytochrome P450
- DILI:
-
Drug-induced liver injury
- Drp1:
-
Dynamin-related protein 1
- GCL:
-
Glutamate cysteine ligase
- GSH:
-
Glutathione
- GSK-3β:
-
Glycogen synthase kinase-3β
- GWAS:
-
Genome-wide association studies
- HLA:
-
Human leukocyte antigen
- JNK:
-
c-Jun N-terminal kinase
- Keap1:
-
Kelch-like ECH-associated protein 1
- LPS:
-
Lipopolysaccharide
- Mcl-1:
-
Induced myeloid leukemia cell differentiation protein
- Mfn:
-
Mitofusin
- MLK3:
-
Mixed-lineage kinase-3
- MOMP:
-
Mitochondrial outer membrane permeabilization
- MPT:
-
Mitochondrial permeability transition
- NAPQI:
-
N-Acetyl-p-benzo-quinoneimine
- Nrf-2:
-
Nuclear factor (erythroid-derived 2)-like-2
- Opa1:
-
Optic atrophy 1
- PGC-1α:
-
Proliferator-activated receptor gamma coactivator-1α
- PKC:
-
Protein kinase C
- RIP1:
-
Receptor-interacting serine/threonine-protein kinase 1
- ROS:
-
Reactive oxygen species
- Sab:
-
SH3 homology associated BTK-binding protein
- SOD:
-
Superoxide dismutase
- TNF:
-
Tumor necrosis factor-α
Bibliography
Adam J, Wuillemin N, Watkins S, Jamin H, Eriksson KK, Villiger P et al (2014) Abacavir induced T cell reactivity from drug naive individuals shares features of allo-immune responses. PLoS One. 9(4):e95339
Alfirevic A, Gonzalez-Galarza F, Bell C, Martinsson K, Platt V, Bretland G et al (2012) In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers. Genome Med. 4(6):51
Alvarez-Sanchez R, Montavon F, Hartung T, Pahler A (2006) Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry. Chem Res Toxicol. 19(8):1106–1116
Antoine DJ, Jenkins RE, Dear JW, Williams DP, McGill MR, Sharpe MR et al (2012) Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol. 56(5):1070–1079
Bajt ML, Farhood A, Lemasters JJ, Jaeschke H (2008) Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity. J Pharmacol Exp Ther. 324(1):8–14
Baulies A, Ribas V, Nunez S, Torres S, Alarcon-Vila C, Martinez L et al (2015) Lysosomal Cholesterol Accumulation Sensitizes To Acetaminophen Hepatotoxicity by Impairing Mitophagy. Sci Rep. 5:18017
Boelsterli UA (2003) Animal models of human disease in drug safety assessment. J Toxicol Sci. 28(3):109–121
Boelsterli UA, Lim PL (2007) Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol. 220(1):92–107
Budas GR, Churchill EN, Disatnik MH, Sun L, Mochly-Rosen D (2010) Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc Res. 88(1):83–92
Burcham PC, Harman AW (1991) Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes. J Biol Chem. 266(8):5049–5054
Cadenas E, Davies KJ (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med. 29(3-4):222–230
Chan DC (2006) Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol. 22:79–99
Chang AH, Sancheti H, Garcia J, Kaplowitz N, Cadenas E, Han D (2014) Respiratory substrates regulate S-nitrosylation of mitochondrial proteins through a thiol-dependent pathway. Chem Res Toxicol. 27(5):794–804
Chen W, Koenigs LL, Thompson SJ, Peter RM, Rettie AE, Trager WF et al (1998) Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol. 11(4):295–301
Churchill EN, Mochly-Rosen D (2007) The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans. 35(Pt 5):1040–1042
Copple IM, Goldring CE, Jenkins RE, Chia AJ, Randle LE, Hayes JD et al (2008) The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system. Hepatology. 48(4):1292–1301
Copple IM, Goldring CE, Kitteringham NR, Park BK (2010) The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity. Handb Exp Pharmacol. 196:233–266
Dahlin DC, Miwa GT, Lu AY, Nelson SD (1984) N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A. 81(5):1327–1331
Daly AK (2012) Using genome-wide association studies to identify genes important in serious adverse drug reactions. Annu Rev Pharmacol Toxicol. 52:21–35
Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe’er I, Floratos A et al (2009) HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 41(7):816–819
Dara L, Johnson H, Suda J, Win S, Gaarde W, Han D et al (2015) Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology. 62(6):1847–1857
Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C (2008) Glycogen Synthase Kinase 3 Inhibition Slows Mitochondrial Adenine Nucleotide Transport and Regulates Voltage-Dependent Anion Channel Phosphorylation. Circ Res. 103:983–991
Ding WX, Yin XM (2012) Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol Chem. 393(7):547–564
Ding WX, Guo F, Ni HM, Bockus A, Manley S, Stolz DB et al (2012a) Parkin and mitofusins reciprocally regulate mitophagy and mitochondrial spheroid formation. J Biol Chem. 287(50):42379–42388
Ding WX, Li M, Biazik JM, Morgan DG, Guo F, Ni HM et al (2012b) Electron microscopic analysis of a spherical mitochondrial structure. J Biol Chem. 287(50):42373–42378
Du K, Farhood A, Jaeschke H (2017) Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity. Arch Toxicol 91:761–773
Fujimoto K, Kumagai K, Ito K, Arakawa S, Ando Y, Oda S et al (2009) Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen. Toxicol Pathol. 37(2):193–200
Gandhi A, Guo T, Ghose R (2010) Role of c-Jun N-terminal kinase (JNK) in regulating tumor necrosis factor-alpha (TNF-alpha) mediated increase of acetaminophen (APAP) and chlorpromazine (CPZ) toxicity in murine hepatocytes. J Toxicol Sci. 35(2):163–173
Garcia J, Han D, Sancheti H, Yap LP, Kaplowitz N, Cadenas E (2010) Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem. 285(51):39646–39654
Goldring CE, Kitteringham NR, Elsby R, Randle LE, Clement YN, Williams DP et al (2004) Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice. Hepatology. 39(5):1267–1276
Gomes LC, Di Benedetto G, Scorrano L (2011) During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol. 13(5):589–598
Gong J, Hoyos B, Acin-Perez R, Vinogradov V, Shabrova E, Zhao F et al (2012) Two protein kinase C isoforms, delta and epsilon, regulate energy homeostasis in mitochondria by transmitting opposing signals to the pyruvate dehydrogenase complex. FASEB J. 26(8):3537–3549
Gunawan BK, Liu ZX, Han D, Hanawa N, Gaarde WA, Kaplowitz N (2006) c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology. 131(1):165–178
Han D, Antunes F, Canali R, Rettori D, Cadenas E (2003a) Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J Biol Chem. 278(8):5557–5563
Han D, Canali R, Rettori D, Kaplowitz N (2003b) Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Mol Pharmacol. 64(5):1136–1144
Han D, Hanawa N, Saberi B, Kaplowitz N (2006a) Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol. 291(1):G1–G7
Han D, Hanawa N, Saberi B, Kaplowitz N (2006b) Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic Biol Med. 41(4):627–639
Han D, Ybanez MD, Ahmadi S, Yeh K, Kaplowitz N (2009) Redox regulation of tumor necrosis factor signaling. Antioxid Redox Signal 11:2245–2263
Han D, Shinohara M, Ybanez MD, Saberi B, Kaplowitz N (2010) Signal transduction pathways involved in drug-induced liver injury. Handb Exp Pharmacol. 196:267–310
Han D, Ybanez MD, Johnson HS, McDonald JN, Mesropyan L, Sancheti H et al (2012) Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterations. J Biol Chem. 287(50):42165–42179
Han D, Dara L, Win S, Than TA, Yuan L, Abbasi SQ et al (2013) Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends Pharmacol Sci. 34(4):243–253
Han D, Johnson HS, Rao MP, Martin G, Sancheti H, Silkwood KH et al (2016) Mitochondrial remodeling in the liver following chronic alcohol feeding to rats. Free Radic Biol Med. 102:100–110
Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz N (2008) Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem. 283(20):13565–13577
Hautekeete ML, Horsmans Y, Van Waeyenberge C, Demanet C, Henrion J, Verbist L et al (1999) HLA association of amoxicillin-clavulanate--induced hepatitis. Gastroenterology. 117(5):1181–1186
Hirata K, Takagi H, Yamamoto M, Matsumoto T, Nishiya T, Mori K et al (2008) Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study. Pharmacogenomics J. 8(1):29–33
Holt M, Ju C (2010) Drug-induced liver injury. Handb Exp Pharmacol. 196:3–27
Hu J, Ramshesh VK, McGill MR, Jaeschke H, Lemasters JJ (2016) Low Dose Acetaminophen Induces Reversible Mitochondrial Dysfunction Associated with Transient c-Jun N-Terminal Kinase Activation in Mouse Liver. Toxicol Sci. 150(1):204–215
Iancu TC, Mason WH, Neustein HB (1977) Ultrastructural abnormalities of liver cells in Reye’s syndrome. Hum Pathol. 8(4):421–431
Ibrahim SH, Akazawa Y, Cazanave SC, Bronk SF, Elmi NA, Werneburg NW et al (2011) Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis. J Hepatol. 54(4):765–772
Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M et al (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature. 486(7404):554–558
Jones DP, Lemasters JJ, Han D, Boelsterli UA, Kaplowitz N (2010) Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. Mol Interv. 10(2):98–111
Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW et al (2004) Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. 113(11):1535–1549
Kaplowitz N (2002) Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis. 22(2):137–144
Kaplowitz N (2005) Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 4(6):489–499
Kaplowitz N, Aw TY, Ookhtens M (1985) The regulation of hepatic glutathione. Annu Rev Pharmacol Toxicol. 25:715–744
Karbowski M, Kurono C, Wozniak M, Ostrowski M, Teranishi M, Nishizawa Y et al (1999) Free radical-induced megamitochondria formation and apoptosis. Free Radic Biol Med. 26(3-4):396–409
Kashimshetty R, Desai VG, Kale VM, Lee T, Moland CL, Branham WS et al (2009) Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity. Toxicol Appl Pharmacol. 238(2):150–159
Kheifets V, Mochly-Rosen D (2007) Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol Res. 55(6):467–476
Kier LD, Neft R, Tang L, Suizu R, Cook T, Onsurez K et al (2004) Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro. Mutat Res. 549(1-2):101–113
Latchoumycandane C, Goh CW, Ong MM, Boelsterli UA (2007) Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. Hepatology. 45(2):412–421
Lee WM (2003) Drug-induced hepatotoxicity. N Engl J Med. 349(5):474–485
Lee KK, Imaizumi N, Chamberland SR, Alder NN, Boelsterli UA (2015) Targeting mitochondria with methylene blue protects mice against acetaminophen-induced liver injury. Hepatology. 61(1):326–336
Liguori MJ, Anderson MG, Bukofzer S, McKim J, Pregenzer JF, Retief J et al (2005) Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin. Hepatology. 41(1):177–186
Liguori MJ, Ditewig AC, Maddox JF, Luyendyk JP, Lehman-McKeeman LD, Nelson DM et al (2010) Comparison of TNFalpha to Lipopolysaccharide as an Inflammagen to Characterize the Idiosyncratic Hepatotoxicity Potential of Drugs: Trovafloxacin as an Example. Int J Mol Sci. 11(11):4697–4714
Lou H, Kaplowitz N (2007) Glutathione depletion down-regulates tumor necrosis factor alpha-induced NF-kappaB activity via IkappaB kinase-dependent and -independent mechanisms. J Biol Chem. 282(40):29470–29481
Lucena MI, Andrade RJ, Martinez C, Ulzurrun E, Garcia-Martin E, Borraz Y et al (2008) Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury. Hepatology. 48(2):588–596
Lucena MI, Garcia-Martin E, Andrade RJ, Martinez C, Stephens C, Ruiz JD et al (2010) Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury. Hepatology. 52(1):303–312
Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ et al (2011) Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology. 141(1):338–347
Luyendyk JP, Maddox JF, Cosma GN, Ganey PE, Cockerell GL, Roth RA (2003) Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats. J Pharmacol Exp Ther. 307(1):9–16
Maddox JF, Amuzie CJ, Li M, Newport SW, Sparkenbaugh E, Cuff CF et al (2010) Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity. J Toxicol Environ Health A. 73(1):58–73
Matsumaru K, Ji C, Kaplowitz N (2003) Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes. Hepatology. 37(6):1425–1434
Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR (2006) Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell. 21(6):749–760
McGill MR, Staggs VS, Sharpe MR, Lee WM, Jaeschke H (2014) Acute Liver Failure Study G. Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology. 60(4):1336–1345
Morimoto T, Tanaka A, Taki Y, Noguchi M, Yokoo N, Nishihira T et al (1988) Changes in concentrations of respiratory components and cytochrome oxidase activity in mitochondria obtained from carbon tetrachloride-induced cirrhotic rat liver. Clin Sci (Lond). 74(5):485–489
Nagai H, Matsumaru K, Feng G, Kaplowitz N (2002) Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatology. 36(1):55–64
Nakagawa H, Maeda S, Hikiba Y, Ohmae T, Shibata W, Yanai A et al (2008) Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology. 135(4):1311–1321
Ni HM, Bockus A, Boggess N, Jaeschke H, Ding WX (2012) Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology. 55(1):222–232
Ni HM, Williams JA, Jaeschke H, Ding WX (2013) Zonated induction of autophagy and mitochondrial spheroids limits acetaminophen-induced necrosis in the liver. Redox biology. 1(1):427–432
O’Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RN et al (2000) Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut. 47(5):717–720
Olafsdottir K, Reed DJ (1988) Retention of oxidized glutathione by isolated rat liver mitochondria during hydroperoxide treatment. Biochim Biophys Acta. 964(3):377–382
Ong MM, Wang AS, Leow KY, Khoo YM, Boelsterli UA (2006) Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2(+/-) mice. Free Radic Biol Med. 40(3):420–429
Ong MM, Latchoumycandane C, Boelsterli UA (2007) Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. Toxicol Sci. 97(1):205–213
Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH et al (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 137(12):947–954
Osterloh J, Cunningham W, Dixon A, Combest D (1989) Biochemical relationships between Reye’s and Reye’s-like metabolic and toxicological syndromes. Med Toxicol Adverse Drug Exp. 4(4):272–294
Otera H, Mihara K (2011) Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem. 149(3):241–251
Porceddu M, Buron N, Roussel C, Labbe G, Fromenty B, Borgne-Sanchez A (2012) Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria. Toxicol Sci. 129(2):332–345
Reddy PH, Reddy TP, Manczak M, Calkins MJ, Shirendeb U, Mao P (2011) Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Rev. 67(1-2):103–118
Roth RA, Ganey PE (2010) Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one? J Pharmacol Exp Ther. 332(3):692–697
Ruepp SU, Tonge RP, Shaw J, Wallis N, Pognan F (2002) Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci. 65(1):135–150
Saberi B, Shinohara M, Ybanez MD, Hanawa N, Gaarde WA, Kaplowitz N et al (2008) Regulation of H(2)O(2)-induced necrosis by PKC and AMP-activated kinase signaling in primary cultured hepatocytes. Am J Physiol Cell Physiol. 295(1):C50–C63
Saberi B, Ybanez MD, Johnson HS, Gaarde WA, Han D, Kaplowitz N (2014) Protein kinase C (PKC) participates in acetaminophen hepatotoxicity through c-jun-N-terminal kinase (JNK)-dependent and -independent signaling pathways. Hepatology. 59:1543–1554
Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM et al (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 362(18):1675–1685
Schwabe RF (2006) Cell death in the liver-all roads lead to JNK. Gastroenterology. 131(1):314–316
Seki E, Brenner DA, Karin M (2012) A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology. 143(2):307–320
Sharma M, Gadang V, Jaeschke A (2012) Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity. Mol Pharmacol. 82(5):1001–1007
Shaw PJ, Hopfensperger MJ, Ganey PE, Roth RA (2007) Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. Toxicol Sci. 100(1):259–266
Shinohara M, Ybanez MD, Win S, Than TA, Jain S, Gaarde WA et al (2010) Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1. J Biol Chem. 285(11):8244–8255
Shiryaeva A, Baidyuk E, Arkadieva A, Okovityy S, Morozov V, Sakuta G (2008) Hepatocyte mitochondrion electron-transport chain alterations in CCl(4) and alcohol induced hepatitis in rats and their correction with simvastatin. J Bioenerg Biomembr. 40(1):27–34
Shishido S, Koga H, Harada M, Kumemura H, Hanada S, Taniguchi E et al (2003) Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes. Hepatology. 37(1):136–147
Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L et al (2010) A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet. 42(8):711–714
Spahr L, Rubbia-Brandt L, Burkhard PR, Assal F, Hadengue A (2000) Tolcapone-related fulminant hepatitis: electron microscopy shows mitochondrial alterations. Dig Dis Sci. 45(9):1881–1884
Thames G (2004) Drug-induced liver injury: what you need to know. Gastroenterol Nurs. 27(1):31–33
Than TA, Lou H, Ji C, Win S, Kaplowitz N (2011) Role of cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 3 (CRTC3) in the initiation of mitochondrial biogenesis and stress response in liver cells. J Biol Chem. 286(25):22047–22054
Tong KI, Padmanabhan B, Kobayashi A, Shang C, Hirotsu Y, Yokoyama S et al (2007) Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol Cell Biol 27(21):7511–7521
Tukov FF, Luyendyk JP, Ganey PE, Roth RA (2007) The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury. Toxicol Sci. 100(1):267–280
Uetrecht J (2009) Immunoallergic drug-induced liver injury in humans. Semin Liver Dis. 29(4):383–392
Ulrich RG (2007) Idiosyncratic toxicity: a convergence of risk factors. Annu Rev Med. 58:17–34
Vick B, Weber A, Urbanik T, Maass T, Teufel A, Krammer PH et al (2009) Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. Hepatology. 49(2):627–636
Watkins PB (2005) Idiosyncratic liver injury: challenges and approaches. Toxicol Pathol. 33(1):1–5
Watkins PB (2009) Biomarkers for the diagnosis and management of drug-induced liver injury. Semin Liver Dis. 29(4):393–399
Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW et al (2006) Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 296(1):87–93
Westermann B (2010) Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol. 11(12):872–884
Wiltshire C, Gillespie DA, May GH (2004) Sab (SH3BP5), a novel mitochondria-localized JNK-interacting protein. Biochem Soc Trans. 32(Pt 6):1075–1077
Win S, Than TA, Han D, Petrovic LM, Kaplowitz N (2011) c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem. 286(40):35071–35078
Win S, Than TA, Fernandez-Checa JC, Kaplowitz N (2014) JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death. Cell Death Dis. 5:e989
Win S, Than TA, Le BH, Garcia-Ruiz C, Fernandez-Checa JC, Kaplowitz N (2015) Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity. J Hepatol. 62(6):1367–1374
Win S, Than TA, Min RW, Aghajan M, Kaplowitz N (2016) c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src. Hepatology. 63(6):1987–2003
Winnike JH, Li Z, Wright FA, Macdonald JM, O’Connell TM, Watkins PB (2010) Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther. 88(1):45–51
Wong GH, Elwell JH, Oberley LW, Goeddel DV (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58(5):923–931
Wu W, Zhao L, Yang P, Zhou W, Li B, Moorhead JF et al (2016) Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice. PLoS One. 11(7):e0159512
Wullaert A, Heyninck K, Beyaert R (2006) Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. Biochem Pharmacol. 72(9):1090–1101
Xu JJ, Henstock PV, Dunn MC, Smith AR, Chabot JR, de Graaf D (2008) Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci. 105(1):97–105
Yin XM, Ding WX, Gao W (2008) Autophagy in the liver. Hepatology. 47(5):1773–1785
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Decker, C.W. et al. (2017). The Critical Role of Mitochondria in Drug-Induced Liver Injury. In: Ding, WX., Yin, XM. (eds) Molecules, Systems and Signaling in Liver Injury. Cell Death in Biology and Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-58106-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-58106-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58105-7
Online ISBN: 978-3-319-58106-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)